Clicky

ALK-Abelló A/S(AKBLF) News

Date Title
Oct 9 Alk-Abello AS (AKBLF) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Upgraded Outlook
Oct 7 ALK Announces U.S. FDA Approval of New AccuTest™ Allergy Skin Testing Devices for Optimized Allergy Testing and Diagnosis
Jun 21 ALK upgrades its full-year revenue and earnings outlook
Jun 21 ALK provides update on regulatory process for the house dust mite allergy tablet in China
Jan 4 ALK to Become Sole Manufacturer and Distributor of Skin Antigen Test for Penicillin Allergy
Dec 20 ALK – Financial calendar for the 2024 financial year